Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Pharmaceutical industry

Gilead’s Patent Loss to Merck Started With a Broken Friendship

Editor's pick
Bloomberg
19 December 2016
Access to healthcare

Hepatitis C patients 'go abroad for drugs'

Editor's pick
BBC Radio 4 (audio)
19 December 2016
Pharmaceutical industry

Merck wins $2.54 billion in hepatitis C drug trial against Gilead

Editor's pick
Reuters
16 December 2016
Hepatitis C treatment

Hepatitis C drugs Australia's most expensive, cost taxpayers $1 billion in four months

Editor's pick
ABC Online
5 December 2016
Access to healthcare

New WHO report shows strategic purchasing of medicines can improve access in the European Region

Editor's pick
World Health Organization
2 December 2016
Hepatitis C treatment

DAA treatment restricted for Canadian hepatitis C patients

Editor's pick
Medical Economics
29 November 2016
Access to healthcare

Where hepatitis C rates are seven times the US average — and a cure is kept out of reach

Editor's pick
STAT
14 November 2016
Access to healthcare

These researchers think they have a solution to the global crisis in drug prices

Editor's pick
Washington Post
8 November 2016
Access to healthcare

Buyers clubs for cheaper drugs help fight hepatitis and HIV

Editor's pick
Reuters
7 November 2016
Hepatitis C treatment

The Cost Of A Cure: Revisiting Medicare Part D And Hepatitis C Drugs

Editor's pick
Health Affairs (blog)
4 November 2016
Pharmaceutical industry

Gilead sales of Hepatitis C drugs slump

Editor's pick
MarketWatch
2 November 2016
Access to healthcare

Over 1 million treated with highly effective hepatitis C medicines

Editor's pick
World Health Organization
27 October 2016
Hepatitis C treatment

A promising Hep C program seems to be working — and it could be a model for other countries

Editor's pick
Business Insider
24 October 2016
Hepatitis C treatment

Eliminating hepatitis C as a major public health threat needs a two-pronged attack

Editor's pick
Public Health England
18 October 2016
Hepatitis C treatment

Punjab hepatitis control programme on verge of collapse

Editor's pick
Daily Times
18 October 2016
Hepatitis C treatment

People infected by hepatitis C in Canada have limited access to direct-acting antivirals

Editor's pick
CRCHUM Montreal
17 October 2016
Pharmaceutical industry

European regulator amends some Gilead hep C patent claims

Editor's pick
STAT
6 October 2016
Hepatitis C treatment

HCV Drugs May Reactivate HBV, FDA Warns

Editor's pick
Medscape (free registration required)
6 October 2016
Hepatitis C treatment

UNITAID and FIND launch initiative to improve diagnostics and treatment for hepatitis C

Editor's pick
UNITAID
4 October 2016
Hepatitis C treatment

Elimination of viral hepatitis by 2030: What's needed and how do we get there?

Editor's pick
European Centre for Disease Prevention and Control (ECDC)
4 October 2016
Hepatitis C treatment

Australia leading world in hepatitis C treatment; but disease more prevalent in Aboriginal people

Editor's pick
ABC Online
29 September 2016
Hepatitis C treatment

NICE says yes to another hepatitis C drug

Editor's pick
NICE
26 September 2016
Hepatitis C treatment

Exviera, Viekirax regimen shows high SVR in HCV genotype 1b after 8 weeks

Editor's pick
Healio
26 September 2016
Hepatitis C treatment

New Study: Negotiated Hepatitis C Prescription Drug Costs in United States Often Lower than in Price-Controlled European Countries and Japan

Editor's pick
Yahoo News
20 September 2016